Periodontal disease and type 2 diabetes mellitus: is the HMGB1-RAGE axis the missing link?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Medical Hypotheses

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mehy.2012.06.020PMID 22800803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HMGB1: the missing link between diabetes mellitus and heart failure

  2010cited by this paper
• Human gingival fibroblasts release high-mobility group box-1 protein through active and passive pathways.

  2009cited by this paper
• Roles of MAPK and NF-κB in Interleukin-6 Induction by Lipopolysaccharide in Vascular Smooth Muscle Cells

  2008cited by this paper
• Relationship between periodontal infections and systemic disease.

  2007cited by this paper
• Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-kappaB, p38, and JNK activation.

  2007cited by this paper
• Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1.

  2007cited by this paper
• Periodontal disease and systemic conditions: a bidirectional relationship

  2006cited by this paper
• Diabetes mellitus and periodontal diseases.

  2006cited by this paper
• HMGB1: guiding immunity from within.

  2005cited by this paper
• Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR.

  2005cited by this paper
• Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein*

  2004cited by this paper
• Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions: Role of Activated Macrophages and Cytokines

  2004cited by this paper
• Activation of Human Umbilical Vein Endothelial Cells Leads to Relocation and Release of High‐Mobility Group Box Chromosomal Protein 1

  2004cited by this paper
• Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines.

  2004cited by this paper
• High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine.

  2003cited by this paper
• The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction.

  2003cited by this paper
• Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

  2002cited by this paper
• Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis.

  2001cited by this paper
• Periodontal disease: bacterial virulence factors, host response and impact on systemic health.

  2000cited by this paper
• Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis

  1999cited by this paper
• Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes.

  1999cited by this paper
• Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

  1999cited by this paper
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• Microbial complexes in subgingival plaque.

  1998cited by this paper
• Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts.

  1998cited by this paper
• Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients.

  1997cited by this paper
• Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases.

  1997cited by this paper
• Bacterially induced bone destruction: mechanisms and misconceptions

  1996cited by this paper
• Characterization of a High Mobility Group 1/2 Homolog in Yeast*

  1996cited by this paper
• The dark side of glucose

  1995cited by this paper
• Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.

  1994cited by this paper
• Periodontal Disease: The sixth complication of diabetes mellitus

  1993cited by this paper
• Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

  1993cited by this paper
• Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

  1992cited by this paper
• Tetracycline administration increases protein (presumably procollagen) synthesis and secretion in periodontal ligament fibroblasts of streptozotocin-induced diabetic rats.

  1992cited by this paper
• Glucose and diabetic vascular disease 1

  1992cited by this paper
• Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.

  1992cited by this paper
• Type 2 diabetes mellitus and periodontal disease.

  1990cited by this paper
• Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions.

  1989cited by this paper
• Endotoxin‐Stimulated Human Monocyte Secretion of Interleukin 1, Tumour Necrosis Factor Alpha, and Prostaglandin E2 Shows Stable Interindividual Differences

  1988cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper
• Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption.

  1987cited by this paper
• Diabetes increases collagenase activity in extracts of rat gingiva and skin.

  1983cited by this paper
• Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes).

  1982cited by this paper
• Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease.

  1981cited by this paper
• Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus.

  1981cited by this paper
• Blockade of RAGE ± amphoterin signalling suppresses tumour growth and metastases

  year unknowncited by this paper

• Pathogenic Interplay Between Diabetes Mellitus and Periodontal Disease

  2025cites this paper
• Salivary and serum levels of high mobility group box protein 1 in periodontitis: a cross-sectional observational study

  2025cites this paper
• Detection of Virulence Factors of Porphyromonas gingivalis and Periodontal Diseases in Chronic Disease Patients

  2025cites this paper
• High Mobility Group Box-1 (HMGB1)/microRNA-155 Axis in the Pathogenesis of Type 2 Diabetes Mellitus Associated Periodontitis: A Case Control Study

  2025cites this paper
• “Medicine food homology” plants promote periodontal health: antimicrobial, anti-inflammatory, and inhibition of bone resorption

  2023cites this paper
• Expression of High Mobility Group Box 1 and Receptor for Advanced Glycation End Products in the Gingival Tissues of Periodontitis Patients with Type 2 Diabetes Mellitus

  2023cites this paper
• Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse

  2022cites this paper
• Paeonol ameliorates diabetic erectile dysfunction by inhibiting HMGB1/RAGE/NF‐kB pathway

  2022cites this paper
• PAMPs and DAMPs as the Bridge Between Periodontitis and Atherosclerosis: The Potential Therapeutic Targets

  2022cites this paper
• High Mobility Group Box 1 Expression in Oral Inflammation and Regeneration

  2020cites this paper
• Association of Receptor for advanced glycation end products G82S polymorphism with chronic periodontitis in type II diabetic and non-diabetic South Indians.

  2019cites this paper
• Glycyrrhizic acid suppresses inflammation and reduces the increased glucose levels induced by the combination of Porphyromonas gulae and ligature placement in diabetic model mice

  2019cites this paper
• Inhibition of HMGB1 Promotes Osseointegration under Hyperglycemic Condition through Improvement of BMSC Dysfunction

  2019cites this paper
• Cigarette smoke extract (CSE) induces RAGE-mediated inflammation in the Ca9-22 gingival carcinoma epithelial cell line.

  2017cites this paper
• Variation de l'expression des formes de rage au cours de la parondontite chronique

  2017cites this paper
• Alterations in Tight Junctional Proteins and Their Effects on Pulmonary Inflammation

  2017cites this paper
• Effects of nonsurgical periodontal therapy in patients with moderately controlled type 2 diabetes mellitus and chronic periodontitis in Nepalese population

  2017cites this paper
• Porphyromonas gingivalis attenuates ATP-mediated inflammasome activation and HMGB1 release through expression of a nucleoside-diphosphate kinase.

  2015cites this paper
• Altered gene expression in gingival tissues and enhanced bone loss in rats with diabetes with experimental periodontitis.

  2014cites this paper
• Serum zinc and magnesium concentrations in type 2 diabetes mellitus with periodontitis

  2014cites this paper
• Turn OFF the CYTOKINE SWITCH

  2014cites this paper
• MICROCIRCULAÇÃO DE PACIENTES DIABÉTICOS COM PERIODONTITE of diabetic patients with periodontitis

  2014cites this paper
• Oral complications of diabetes: an under-recognised condition

  2014cites this paper
• HMGB1 Localization during Experimental Periodontitis

  2014cites this paper
• Oral complications of diabetes: an under-recognized condition

  2013cites this paper
• Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke

  2013cites this paper